MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Travere Therapeutics, Inc. Common Stock

TVTX

#1492
Travere Therapeutics, Inc. Common Stock
29.7900
+3.83%
Sector:
Base:
Profit Currency:
Daily Range
29.7900
29.7900
Year Range
22.5900
42.1300
Daily Change
+3.83%
Monthly Change
-0.37%
6 month change
+3.55%
Year Change
+3.55%
Previous Close
28.6900
Open
29.7900
Bid
Ask
Low
29.7900
High
29.7900
Volume
138
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. TVTX
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 202020212022202320242025 TTM

News

Seeking Alpha Seeking Alpha
TVTX
2026.02.24
Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)
Seeking Alpha Seeking Alpha
TVTX
2026.02.20
Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript
Zacks Zacks
TVTX RXRX
2026.02.19
Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates
Seeking Alpha Seeking Alpha
TVTX
2026.02.19
Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19
Investing Investing
TVTX
2026.02.19
Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss
Investing Investing
TVTX
2026.02.19
Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates
Investing Investing
AKAM CNP SO WMT GFI
2026.02.18
Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday
Zacks Zacks
KNSA TVTX
2026.02.17
Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?
Zacks Zacks
TVTX
2026.02.12
Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?
Investing Investing
TVTX
2026.02.11
Travere Therapeutics at Guggenheim Summit: Confident in Strategic Path
Zacks Zacks
NRIX TVTX
2026.01.28
Nurix Therapeutics, Inc. (NRIX) Reports Q4 Loss, Misses Revenue Estimates
Investing Investing
TVTX
2026.01.28
Travere therapeutics CEO Dube sells $1.8 million in TVTX stock

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd